4.2 Article

Myeloproliferative Neoplasm Animal Models

Journal

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Volume 26, Issue 5, Pages 1065-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2012.07.007

Keywords

Myeloproliferative neoplasms; Preclinical murine models; BCR-ABL; JAK2V617F; Hematopoietic stem cells; Bone marrow microenvironment; Myelofibrosis; Oncogenes

Funding

  1. NCI NIH HHS [P01 CA066996] Funding Source: Medline
  2. NHLBI NIH HHS [R01 HL082945, K08 HL109734] Funding Source: Medline

Ask authors/readers for more resources

Myeloproliferative neoplasm (MPN) animal models accurately re-capitulate human disease in mice and have been an important tool for the study of MPN biology and therapy. Transplantation of BCR-ABL transduced bone marrow into irradiated syngeneic mice established the field of MPN animal modeling. Genetically engineered MPN animal models have enabled detailed characterization of the effects of specific MPN-associated genetic abnormalities on hematopoietic stem and progenitor cells (HSPCs). Xenograft models have allowed the study of primary human MPN-propagating cells in vivo. JAK2V617F, the most common molecular abnormality in BCR-ABL negative MPN, has been extensively studied using retroviral, transgenic, knock-in and xenograft models.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available